Action Point Financial Planning’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4
Closed -$256 – 1588
2026
Q2
$256 Buy
+4
New +$207 ﹤0.01% 2690

Other funds holding KNSA

Action Point Financial Planning's KNSA Position: Q3 2026 in Review

Action Point Financial Planning sold out of Kiniksa Pharmaceuticals (KNSA) in Q3 2026, closing a stake of 4 shares — an estimated $256 sold.

Action Point Financial Planning first reported a position in KNSA in Q2 2026 and held it in 1 quarter. The position peaked at $256 in Q2 2026. 305 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • Action Point Financial Planning reported no remaining Kiniksa Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 4 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $256.
  • Action Point Financial Planning first reported a position in Kiniksa Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's Kiniksa Pharmaceuticals position peaked at $256 in Q2 2026.
  • 305 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.